Dolutegravir and Ziagen drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Dolutegravir (dolutegravir) and Ziagen (abacavir sulfate). Common drug interactions include pruritus among females and osteoporosis among males.
The phase IV clinical study analyzes what interactions people have when they take Dolutegravir and Ziagen. It is created by eHealthMe based on reports of 100 people who take the same drugs from the FDA, and is updated regularly.
What is Dolutegravir?
Dolutegravir has active ingredients of dolutegravir. eHealthMe is studying from 7,071 Dolutegravir users. Check the latest studies of Dolutegravir.
What is Ziagen?
Ziagen has active ingredients of abacavir sulfate. It is often used in hiv infection. eHealthMe is studying from 7,626 Ziagen users. Check the latest studies of Ziagen.
100 people who take Dolutegravir and Ziagen together, and have interactions are studied.

What are the common drug interactions of Dolutegravir and Ziagen, by gender? *:
female:
- Pruritus (severe itching of the skin)
- Pyrexia (fever)
- Rash
- Renal failure (kidney dysfunction)
male:
- Osteoporosis (bones weak and more likely to break)
- Depressive symptom
- Pain
- Anxiety
- Leukopenia (less number of white blood cells in blood)
- Renal failure (kidney dysfunction)
- Insomnia (sleeplessness)
- Renal impairment (severely reduced kidney function)
- Abdominal discomfort
- Chronic kidney disease
What are the common drug interactions of Dolutegravir and Ziagen, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Emotional distress
- Renal failure (kidney dysfunction)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Pain
30-39:
n/a
40-49:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Chronic kidney disease
- Emotional distress
- Pain
- Hypertriglyceridaemia (excess of triglycerides in the blood)
- Neuropathy peripheral (surface nerve damage)
- Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
- Anxiety
- Bone loss
- Cerebral haemorrhage (bleeding within the brain)
50-59:
- Renal impairment (severely reduced kidney function)
- Osteoporosis (bones weak and more likely to break)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Chronic kidney disease
- Emotional distress
- Multiple injuries
- Nephrolithiasis (calculi in the kidneys)
- Pain
- Dehydration (dryness resulting from the removal of water)
60+:
- Renal disorder (kidney disease)
- Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously)
- Renal failure (kidney dysfunction)
- Renal impairment (severely reduced kidney function)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Decreased activity
- Emotional distress
- Nephropathy toxic (damage to kidney due to toxins)
- Pain
What are the existing conditions these people have? *
- High Blood Pressure: 22 people, 22.00%
- Retinal Disorder (disease of retina): 18 people, 18.00%
- Mycobacterium Avium Complex Infection: 18 people, 18.00%
- Cerebral Toxoplasmosis (parasitic disease of brain caused by the protozoan toxoplasma gondii): 18 people, 18.00%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 17 people, 17.00%
- Depression: 12 people, 12.00%
- Insomnia (sleeplessness): 8 people, 8.00%
- Hepatitis B: 7 people, 7.00%
- Depressed Mood: 7 people, 7.00%
- Hypersensitivity: 6 people, 6.00%
* Approximation only. Some reports may have incomplete information.
Do you take Dolutegravir and Ziagen?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Dolutegravir (7,071 reports)
- Ziagen (7,626 reports)
Browse all drug interactions of Dolutegravir and Ziagen:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Dolutegravir:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ziagen:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Dolutegravir and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ziagen and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on dolutegravir and abacavir sulfate (the active ingredients of Dolutegravir and Ziagen, respectively), and Dolutegravir and Ziagen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Remicade cause Fistula? - 8 seconds ago
- How effective is Venlafaxine Hydrochloride for Generalized Anxiety Disorder? - 9 seconds ago
- Could Herceptin cause Nail Abnormalities? - 12 seconds ago
- Drug interactions of Olmesartan Medoxomil and Olanzapine - 23 seconds ago
- Drug interactions of Olanzapine and Theophylline - 23 seconds ago
- Could Tacrolimus cause Angina Pectoris Aggravated? - 27 seconds ago
- Drug interactions of Olanzapine and Brintellix - 29 seconds ago
- Could Flonase cause Pulmonary Function Test Decreased? - 44 seconds ago
- Could Maxalt cause Infusion Related Reaction? - 46 seconds ago
- Could Abraxane cause White Blood Cell Count Decreased? - 56 seconds ago